Found: 108
Select item for more details and to access through your institution.
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7547, doi. 10.1007/s00432-023-04704-3
- By:
- Publication type:
- Article
Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid–enhanced MRI: long-term follow-up in a surveillance cohort.
- Published in:
- European Radiology, 2022, v. 32, n. 8, p. 5064, doi. 10.1007/s00330-022-08623-8
- By:
- Publication type:
- Article
Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure.
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 10, p. 1115, doi. 10.1007/s00535-012-0570-7
- By:
- Publication type:
- Article
Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors.
- Published in:
- Journal of Gastroenterology, 2007, v. 42, n. 5, p. 382, doi. 10.1007/s00535-007-2016-1
- By:
- Publication type:
- Article
Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification.
- Published in:
- World Journal of Surgery, 2017, v. 41, n. 5, p. 1347, doi. 10.1007/s00268-016-3837-y
- By:
- Publication type:
- Article
Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma.
- Published in:
- World Journal of Surgery, 2016, v. 40, n. 5, p. 1200, doi. 10.1007/s00268-015-3373-1
- By:
- Publication type:
- Article
Multiple imputation analysis for propensity score matching with missing causes of failure: An application to hepatocellular carcinoma data.
- Published in:
- Statistical Methods in Medical Research, 2021, v. 30, n. 10, p. 2313, doi. 10.1177/09622802211037075
- By:
- Publication type:
- Article
Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
- Published in:
- Journal of Medical Virology, 2016, v. 88, n. 9, p. 1576, doi. 10.1002/jmv.24512
- By:
- Publication type:
- Article
Lack of association between hepatitis B virus pre-S mutations and recurrence after surgical resection in hepatocellular carcinoma.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 4, p. 589, doi. 10.1002/jmv.23502
- By:
- Publication type:
- Article
Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006.
- Published in:
- Journal of Medical Virology, 2008, v. 80, n. 5, p. 777, doi. 10.1002/jmv.21127
- By:
- Publication type:
- Article
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1223, doi. 10.1111/apt.17933
- By:
- Publication type:
- Article
Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 4, p. 515, doi. 10.1111/apt.17819
- By:
- Publication type:
- Article
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 217, doi. 10.1111/apt.17764
- By:
- Publication type:
- Article
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 3, p. 519, doi. 10.1111/apt.17052
- By:
- Publication type:
- Article
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 1044, doi. 10.1111/apt.16886
- By:
- Publication type:
- Article
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 921, doi. 10.1111/apt.16788
- By:
- Publication type:
- Article
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 6, p. 763, doi. 10.1111/apt.16278
- By:
- Publication type:
- Article
East Asia expert opinion on treatment initiation for chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1540, doi. 10.1111/apt.16097
- By:
- Publication type:
- Article
Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 576, doi. 10.1111/apt.15881
- By:
- Publication type:
- Article
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
- By:
- Publication type:
- Article
Is Serum Alpha-Fetoprotein Useful for Predicting Recurrence and Mortality Specific to Hepatocellular Carcinoma After Hepatectomy? A Test Based on Propensity Scores and Competing Risks Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 12, p. 3687, doi. 10.1245/s10434-012-2416-1
- By:
- Publication type:
- Article
Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 3, p. 869, doi. 10.1245/s10434-009-0788-7
- By:
- Publication type:
- Article
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 496, doi. 10.1007/s10637-017-0548-7
- By:
- Publication type:
- Article
Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns.
- Published in:
- Hepatology Research, 2013, v. 43, n. 12, p. 1304, doi. 10.1111/hepr.12083
- By:
- Publication type:
- Article
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135298
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079854
- By:
- Publication type:
- Article
A Novel Estimation of the Relative Economic Value in Terms of Different Chronic Hepatitis B Treatment Options.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0057900
- By:
- Publication type:
- Article
Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 897, doi. 10.1007/s00277-011-1380-3
- By:
- Publication type:
- Article
A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid‐Enhanced MRI Features.
- Published in:
- Journal of Magnetic Resonance Imaging, 2022, v. 55, n. 6, p. 1877, doi. 10.1002/jmri.27962
- By:
- Publication type:
- Article
Combined Hepatocellular‐Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.
- Published in:
- Journal of Magnetic Resonance Imaging, 2021, v. 53, n. 6, p. 1803, doi. 10.1002/jmri.27528
- By:
- Publication type:
- Article
Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
- Published in:
- Journal of Magnetic Resonance Imaging, 2015, v. 41, n. 4, p. 1115, doi. 10.1002/jmri.24660
- By:
- Publication type:
- Article
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 23, doi. 10.1007/s00262-018-2247-4
- By:
- Publication type:
- Article
Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1968, doi. 10.3390/cancers12071968
- By:
- Publication type:
- Article
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B: A Multinational Study for the Development and External Validation of a New Prognostic Model.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 10, p. 1308, doi. 10.7326/M24-0384
- By:
- Publication type:
- Article
A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241808
- By:
- Publication type:
- Article
Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2021, v. 37, n. 4, p. 262, doi. 10.1002/kjm2.12364
- By:
- Publication type:
- Article
Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1243, doi. 10.1111/liv.15877
- By:
- Publication type:
- Article
Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 2080, doi. 10.1111/liv.15110
- By:
- Publication type:
- Article
Liver Imaging Reporting and Data System categories: Long‐term imaging outcomes in a prospective surveillance cohort.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1648, doi. 10.1111/liv.15276
- By:
- Publication type:
- Article
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1517, doi. 10.1111/liv.15261
- By:
- Publication type:
- Article
Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population‐based study.
- Published in:
- Liver International, 2021, v. 41, n. 11, p. 2777, doi. 10.1111/liv.15011
- By:
- Publication type:
- Article
Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2189, doi. 10.1111/liv.14932
- By:
- Publication type:
- Article
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1398, doi. 10.1111/liv.14813
- By:
- Publication type:
- Article
Surgical resection versus radiofrequency ablation very early‐stage HCC (≤2 cm Single HCC): A propensity score analysis.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2397, doi. 10.1111/liv.14258
- By:
- Publication type:
- Article
Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.
- Published in:
- Liver International, 2019, v. 39, n. 5, p. 985, doi. 10.1111/liv.14082
- By:
- Publication type:
- Article
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 503, doi. 10.1111/liv.13555
- By:
- Publication type:
- Article